Home / Health / Guernsey Trial: Weight Loss Jabs to Aid 300
Guernsey Trial: Weight Loss Jabs to Aid 300
30 Jan
Summary
- Up to 300 people will join a two-year weight loss jab trial.
- Medication mimics natural hormones to control appetite.
- Trial aims to improve health and potentially reduce costs.
A significant weight loss medication trial is set to commence in Guernsey, involving up to 300 participants over a two-year period. This trial could pave the way for the weight loss jabs to become available via prescription, according to government announcements.
President of health and social care, George Oswald, a medical doctor, emphasized the medication's efficacy, stating it delivers results much more quickly and effectively than conventional methods. Currently, the drug is used to treat type 2 diabetes patients.
The trial, managed by Public Health, will assess the medication's health improvement benefits. Oswald expressed hope that positive results would encourage the extension of the drug's rollout. He noted that obesity, particularly morbid obesity, affects numerous health conditions, including cancer and osteoarthritis, and the medication's appetite-controlling properties could significantly mitigate these risks.
